Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172772 | SCV000051584 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000172772 | SCV000170635 | benign | not specified | 2013-11-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000172772 | SCV000269403 | benign | not specified | 2014-10-29 | criteria provided, single submitter | clinical testing | p.Pro1135Thr in exon 18 of MYPN: This variant is not expected to have clinical s ignificance because it has been identified in 48% (4116/8600) of European Americ an chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.e du/EVS/; dbSNP rs7079481). |
Ambry Genetics | RCV000252665 | SCV000317454 | benign | Cardiovascular phenotype | 2015-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000172772 | SCV000740632 | benign | not specified | 2016-05-13 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625362 | SCV000745066 | benign | Dilated cardiomyopathy 1KK | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000625362 | SCV001000086 | benign | Dilated cardiomyopathy 1KK | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625362 | SCV002015964 | benign | Dilated cardiomyopathy 1KK | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001778667 | SCV002015965 | benign | MYPN-related myopathy | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000172772 | SCV003928620 | likely benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Leiden Muscular Dystrophy |
RCV000024493 | SCV000045797 | not provided | not provided | 2012-04-27 | no assertion provided | curation | |
Clinical Genetics, |
RCV000172772 | SCV001925933 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000172772 | SCV001957846 | benign | not specified | no assertion criteria provided | clinical testing |